世界のバイオ医薬品製造消耗品試験の市場規模は、2023年に5億7,200万ドルと評価され、2024年から2030年にかけて12.3%のCAGRで成長すると予測されます。バイオ医薬品の製造を成功させ、効率的に行うには、製造時に使用される消耗品の純度と品質に大きく依存します。溶解性の悪さ、分子サイズの増大、吸収特性の悪さなど、新規治療薬の品質に関する問題が増大する中、賦形剤やその他の原材料のさまざまな特性の探索に注目が集まっています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Movement Analysis, USD Million, 2023 & 2030
4.3. Laboratory Testing
4.3.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
4.4. Custom Testing / Customer Proprietary Testing
4.4.1. Custom Testing / Customer Proprietary Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
4.5. Compendial & Multi Compendial Laboratory Testing
4.5.1. Compendial & Multi Compendial Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Movement Analysis, USD Million, 2023 & 2030
5.3. Formulation Excipients
5.3.1. Formulation Excipients Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
5.4. Active Pharmaceutical Ingredients (API)
5.4.1. Active Pharmaceutical Ingredients (API) Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
5.5. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
5.5.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis
6.1. Biopharmaceuticals Manufacturing Consumables Testing Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
6.2.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3. Europe
6.3.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.4. France
6.3.4.1. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.2. China
6.4.2.1. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.4. India
6.4.4.1. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Alcami Corporation
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Merck KGaA
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Eurofins Scientific
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Agilent Technologies, Inc.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Charles River Laboratories.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Catalent, Inc
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. Element Materials Technology (Avomeen Analytical Services)
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Pace Analytical Services, LLC
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
